No Scientific Link Found Between Sickle Cell Trait and Sudden Death – Hematology.org
No Scientific Link Found Between Sickle Cell Trait and Sudden Death
Related Articles
FDA Grants Fast Track Status to SIGX1094 for Diffuse Gastric Cancer
SIGX1094 received fast track designation from the FDA for diffuse gastric cancer.
Human CSPG4-targeting CAR-macrophages inhibit melanoma growth
Oncogene – Human CSPG4-targeting CAR-macrophages inhibit melanoma growth
Epcoritamab Gains Japanese Approval for R/R Follicular Lymphoma
The Ministry of Health, Labour, and Welfare in Japan has approved epcoritamab for relapsed or refractory follicular lymphoma.
Melvin Chua: The beauty of academic medicine in global oncology collaboration – OncoDaily
Melvin Chua: The beauty of academic medicine in global oncology collaboration / academic medicine, cancer, Head and Neck Cancer, Melvin Chua, NPC patients,
Wiley Colorectal Cancer Awareness Collection: Cancer Medicine
Cancer Medicine is an open access, broad-scope oncology journal covering clinical cancer research, cancer biology, cancer prevention, & bioinformatics.
A CDK4-selective inhibitor puts the brakes on cancer cells
In this issue of Cancer Cell, Palmer et al. describe the discovery and preclinical testing of the first-in-class CDK4-selective inhibitor atirmociclib. By sparing CDK6, atirmociclib has…
Tambiciclib Plus Zanubrutinib Delivers Responses in R/R DLBCL
Tambiciclib plus zanubrutinib generated responses in patients with relapsed/refractory diffuse large B-cell lymphoma.